Verastem stock price target maintained at $18 by BTIG on trial data

Markets Investing.com By Investing.com 24 Jun 2026 08:20 1 min read

Verastem stock price target maintained at $18 by BTIG on trial data

Verastem stock price target maintained at $18 by BTIG on trial data

Verastem stock price target maintained at $18 by BTIG on trial data

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.